 Hui-Ming Chang
Concepts (152)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neoplasms | 7 | 2020 | 1255 | 1.210 |
Why?
| | Disease Management | 2 | 2017 | 178 | 1.040 |
Why?
| | Cardiovascular Diseases | 4 | 2020 | 460 | 1.020 |
Why?
| | Small Ubiquitin-Related Modifier Proteins | 2 | 2020 | 16 | 0.720 |
Why?
| | Thromboembolism | 1 | 2017 | 55 | 0.550 |
Why?
| | Thrombosis | 1 | 2017 | 250 | 0.460 |
Why?
| | Antineoplastic Agents | 2 | 2019 | 1172 | 0.420 |
Why?
| | Pain Management | 2 | 2004 | 180 | 0.340 |
Why?
| | Hypertension | 2 | 2023 | 544 | 0.280 |
Why?
| | Corticotropin-Releasing Hormone | 2 | 2023 | 14 | 0.250 |
Why?
| | Analgesics | 2 | 1999 | 116 | 0.240 |
Why?
| | TNF Receptor-Associated Factor 6 | 2 | 2021 | 9 | 0.230 |
Why?
| | Autoantigens | 2 | 2021 | 48 | 0.230 |
Why?
| | Signal Transduction | 5 | 2023 | 1624 | 0.210 |
Why?
| | Cell Cycle Proteins | 2 | 2021 | 161 | 0.210 |
Why?
| | Dipeptidyl Peptidase 4 | 1 | 2023 | 10 | 0.210 |
Why?
| | Toll-Like Receptors | 2 | 2021 | 27 | 0.200 |
Why?
| | KCNQ3 Potassium Channel | 1 | 2022 | 4 | 0.200 |
Why?
| | Sympathetic Nervous System | 1 | 2022 | 19 | 0.200 |
Why?
| | Medulla Oblongata | 1 | 2022 | 21 | 0.200 |
Why?
| | KCNQ2 Potassium Channel | 1 | 2022 | 9 | 0.190 |
Why?
| | Potassium | 1 | 2022 | 58 | 0.190 |
Why?
| | Casein Kinase II | 1 | 2021 | 10 | 0.190 |
Why?
| | Glycosylphosphatidylinositols | 7 | 1994 | 32 | 0.190 |
Why?
| | Phosphoprotein Phosphatases | 1 | 2021 | 17 | 0.190 |
Why?
| | Animals | 14 | 2023 | 13124 | 0.190 |
Why?
| | Arterial Pressure | 1 | 2022 | 45 | 0.190 |
Why?
| | Toll-Like Receptor 4 | 1 | 2021 | 52 | 0.190 |
Why?
| | Leukemia, Myeloid, Acute | 1 | 2023 | 181 | 0.180 |
Why?
| | Immunity, Innate | 2 | 2021 | 105 | 0.180 |
Why?
| | Adaptive Immunity | 1 | 2020 | 32 | 0.180 |
Why?
| | Protein Processing, Post-Translational | 1 | 2020 | 156 | 0.160 |
Why?
| | Macrophages | 2 | 2021 | 364 | 0.160 |
Why?
| | Combined Modality Therapy | 2 | 2017 | 641 | 0.160 |
Why?
| | Pain | 3 | 2004 | 389 | 0.160 |
Why?
| | Humans | 13 | 2023 | 50516 | 0.150 |
Why?
| | Morbidity | 1 | 2017 | 130 | 0.140 |
Why?
| | Diabetes Mellitus | 1 | 2020 | 279 | 0.140 |
Why?
| | Sepsis | 1 | 2018 | 225 | 0.120 |
Why?
| | Neurons | 3 | 2023 | 452 | 0.120 |
Why?
| | Incidence | 1 | 2017 | 1032 | 0.110 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2019 | 1000 | 0.110 |
Why?
| | Rats, Inbred WKY | 2 | 2023 | 34 | 0.100 |
Why?
| | Mice | 7 | 2023 | 5687 | 0.100 |
Why?
| | Rats | 4 | 2023 | 3292 | 0.100 |
Why?
| | Rheumatic Diseases | 1 | 1992 | 15 | 0.100 |
Why?
| | Glycolipids | 4 | 1992 | 8 | 0.100 |
Why?
| | Phosphatidylinositols | 4 | 1992 | 27 | 0.100 |
Why?
| | Hemoglobinuria, Paroxysmal | 3 | 1994 | 9 | 0.080 |
Why?
| | Enkephalin, Methionine | 1 | 1989 | 3 | 0.080 |
Why?
| | Substance P | 1 | 1989 | 28 | 0.080 |
Why?
| | Receptors, Opioid | 1 | 1989 | 18 | 0.080 |
Why?
| | Neurons, Afferent | 1 | 1989 | 30 | 0.080 |
Why?
| | Risk Factors | 1 | 2017 | 3723 | 0.080 |
Why?
| | Fentanyl | 1 | 1989 | 36 | 0.080 |
Why?
| | Morphine | 1 | 1989 | 101 | 0.080 |
Why?
| | Pyrrolidines | 1 | 1989 | 67 | 0.080 |
Why?
| | Spinal Cord | 1 | 1989 | 173 | 0.070 |
Why?
| | Disease Models, Animal | 2 | 2023 | 1436 | 0.070 |
Why?
| | Cytokines | 2 | 2021 | 606 | 0.070 |
Why?
| | Mice, Inbred C57BL | 2 | 2022 | 1808 | 0.070 |
Why?
| | N-Methylaspartate | 1 | 2022 | 27 | 0.050 |
Why?
| | Receptors, Corticotropin-Releasing Hormone | 1 | 2022 | 8 | 0.050 |
Why?
| | Neuroanatomical Tract-Tracing Techniques | 1 | 2022 | 2 | 0.050 |
Why?
| | Vesicular Glutamate Transport Protein 2 | 1 | 2022 | 6 | 0.050 |
Why?
| | Rats, Inbred SHR | 1 | 2022 | 42 | 0.050 |
Why?
| | Luminescent Proteins | 1 | 2022 | 53 | 0.050 |
Why?
| | Membrane Potentials | 1 | 2022 | 117 | 0.050 |
Why?
| | Stem Cells | 1 | 2023 | 166 | 0.050 |
Why?
| | Palliative Care | 1 | 2004 | 190 | 0.050 |
Why?
| | Chemokines | 1 | 2021 | 75 | 0.050 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2022 | 140 | 0.050 |
Why?
| | Receptors, N-Methyl-D-Aspartate | 1 | 2022 | 127 | 0.050 |
Why?
| | T-Lymphocytes | 2 | 1994 | 325 | 0.040 |
Why?
| | Lipopolysaccharides | 1 | 2021 | 197 | 0.040 |
Why?
| | Mice, Transgenic | 1 | 2022 | 540 | 0.040 |
Why?
| | Phosphorylation | 1 | 2021 | 525 | 0.040 |
Why?
| | DNA Topoisomerases, Type II | 1 | 2019 | 15 | 0.040 |
Why?
| | Molecular Targeted Therapy | 1 | 2019 | 123 | 0.040 |
Why?
| | Medical Oncology | 1 | 2019 | 99 | 0.040 |
Why?
| | Terminal Care | 1 | 1999 | 46 | 0.040 |
Why?
| | Peripheral Nervous System Diseases | 1 | 1999 | 58 | 0.040 |
Why?
| | Syndrome | 1 | 1999 | 240 | 0.040 |
Why?
| | Interleukin-1 Receptor-Associated Kinases | 1 | 2018 | 11 | 0.040 |
Why?
| | Pain Measurement | 1 | 1999 | 270 | 0.040 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 1999 | 121 | 0.040 |
Why?
| | HEK293 Cells | 1 | 2018 | 213 | 0.040 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2018 | 135 | 0.040 |
Why?
| | Receptors, Tumor Necrosis Factor | 1 | 1996 | 38 | 0.030 |
Why?
| | Nuclear Proteins | 1 | 2018 | 238 | 0.030 |
Why?
| | Severity of Illness Index | 1 | 1999 | 978 | 0.030 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 1996 | 198 | 0.030 |
Why?
| | Repressor Proteins | 1 | 1996 | 148 | 0.030 |
Why?
| | Saccharomyces cerevisiae Proteins | 1 | 1996 | 138 | 0.030 |
Why?
| | Hybridomas | 2 | 1992 | 10 | 0.030 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 1996 | 393 | 0.030 |
Why?
| | Acylation | 1 | 1994 | 7 | 0.030 |
Why?
| | Mannose | 1 | 1994 | 16 | 0.030 |
Why?
| | Ethanolamines | 1 | 1994 | 13 | 0.030 |
Why?
| | Chromosome Mapping | 1 | 1994 | 153 | 0.030 |
Why?
| | Glycosylation | 1 | 1994 | 102 | 0.030 |
Why?
| | Lymphocyte Activation | 1 | 1994 | 164 | 0.030 |
Why?
| | Analgesics, Opioid | 1 | 1999 | 575 | 0.030 |
Why?
| | Male | 2 | 2022 | 25913 | 0.020 |
Why?
| | Apoptosis | 1 | 1996 | 1097 | 0.020 |
Why?
| | Genes, Fungal | 1 | 1990 | 35 | 0.020 |
Why?
| | Transfection | 1 | 1990 | 356 | 0.020 |
Why?
| | Membrane Glycoproteins | 1 | 1991 | 245 | 0.020 |
Why?
| | Membrane Proteins | 1 | 1992 | 332 | 0.020 |
Why?
| | Base Sequence | 3 | 1996 | 639 | 0.020 |
Why?
| | Sufentanil | 1 | 1989 | 1 | 0.020 |
Why?
| | 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer | 1 | 1989 | 4 | 0.020 |
Why?
| | Molecular Sequence Data | 3 | 1996 | 778 | 0.020 |
Why?
| | Chick Embryo | 1 | 1989 | 83 | 0.020 |
Why?
| | Receptors, Opioid, kappa | 1 | 1989 | 39 | 0.020 |
Why?
| | Mutation | 2 | 1992 | 1281 | 0.020 |
Why?
| | Cell Line | 3 | 1993 | 988 | 0.020 |
Why?
| | Amino Acid Sequence | 2 | 1996 | 574 | 0.010 |
Why?
| | Fas-Associated Death Domain Protein | 1 | 1996 | 6 | 0.010 |
Why?
| | SUMO-1 Protein | 1 | 1996 | 25 | 0.010 |
Why?
| | Ubiquitins | 1 | 1996 | 39 | 0.010 |
Why?
| | Protein Conformation | 1 | 1996 | 162 | 0.010 |
Why?
| | Fungal Proteins | 1 | 1996 | 123 | 0.010 |
Why?
| | Recombinant Proteins | 1 | 1996 | 476 | 0.010 |
Why?
| | Carrier Proteins | 1 | 1996 | 298 | 0.010 |
Why?
| | Protein Binding | 1 | 1996 | 654 | 0.010 |
Why?
| | Crossing Over, Genetic | 1 | 1994 | 7 | 0.010 |
Why?
| | Mice, Inbred C3H | 1 | 1994 | 85 | 0.010 |
Why?
| | Meiosis | 1 | 1994 | 64 | 0.010 |
Why?
| | Carbohydrate Sequence | 1 | 1993 | 11 | 0.010 |
Why?
| | Genetic Complementation Test | 1 | 1993 | 48 | 0.010 |
Why?
| | DNA, Complementary | 1 | 1993 | 133 | 0.010 |
Why?
| | Cloning, Molecular | 1 | 1993 | 190 | 0.010 |
Why?
| | Phosphatidylinositol Diacylglycerol-Lyase | 1 | 1992 | 4 | 0.010 |
Why?
| | Glucosamine | 1 | 1992 | 9 | 0.010 |
Why?
| | Phosphoinositide Phospholipase C | 1 | 1992 | 4 | 0.010 |
Why?
| | Phospholipase D | 1 | 1992 | 7 | 0.010 |
Why?
| | Chromatography, Thin Layer | 1 | 1992 | 24 | 0.010 |
Why?
| | Inositol | 1 | 1992 | 19 | 0.010 |
Why?
| | Mammals | 1 | 1992 | 50 | 0.010 |
Why?
| | Phosphoric Diester Hydrolases | 1 | 1992 | 33 | 0.010 |
Why?
| | Cell-Free System | 1 | 1991 | 13 | 0.010 |
Why?
| | Autoradiography | 1 | 1991 | 33 | 0.010 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 1991 | 98 | 0.010 |
Why?
| | Polysaccharides | 1 | 1991 | 51 | 0.010 |
Why?
| | Dolichol Monophosphate Mannose | 1 | 1990 | 1 | 0.010 |
Why?
| | Antigens, Ly | 1 | 1990 | 9 | 0.010 |
Why?
| | Antigens, Surface | 1 | 1990 | 44 | 0.010 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 1991 | 326 | 0.010 |
Why?
| | Cells, Cultured | 1 | 1993 | 1571 | 0.010 |
Why?
| | Cell Membrane | 1 | 1990 | 246 | 0.010 |
Why?
| | Saccharomyces cerevisiae | 1 | 1990 | 175 | 0.010 |
Why?
|
|
Chang's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|